Back

Cardiac Myosin inhibitor improves mid-ventricular obstruction in hypertrophic cardiomyopathy

29 August 2026 (12:20 - 12:30)
Organised by: Logo
Congress Presentation Part of: New insights into hypertrophic cardiomyopathy Hypertrophic Cardiomyopathy ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Luan Lina

Shanghai Geriatric Medical Center, Shanghai (China)

3 More presentations in this session

Presentation thumbnail
Gene-specific reclassification patterns of variants in hypertrophic cardiomyopathy
Doctor A. Bakalakos (London, GB)
Abstract Slides Video
Presentation thumbnail
Extracellular vesicles in hypertrophic cardiomyopathy patients
Associate Professor M. Ruscica (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Family screening outcomes in gene-elusive HCM
Doctor P. Martin Marin (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
New insights into hypertrophic cardiomyopathy
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 12:20 CET
You may be interested in
thumbnail
Congress Session
Cardiac myosin inhibitors for treatment of hypertrophic obstructive cardiomyopathy
2 September 2024
thumbnail
Congress Presentation
Correlation of electrocardiographic reverse remodelling with treatment response to mavacamten in hypertrophic obstructive cardiomyopathy
31 August 2026
thumbnail
Congress Presentation
Expanding the role of myosin inhibition: mavacamten in apical hypertrophic cardiomyopathy with mid-ventricular obstruction
11 May 2026
thumbnail
Congress Presentation
Real-world insights into mavacamten use for obstructive hypertrophic cardiomyopathy: symptomatic improvement before gradient reduction?
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources